Diane Damotte et al.
The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort
Journal of Translational Medicine 2019, vol. 17, issue 1
doi: 10.1186/s12967-019-2100-3
![Logo France Génomique](https://wordpressdev.france-genomique.org/wp-content/uploads/2019/03/logo-FG-blue-RVB-medium.png)
Diane Damotte et al.
The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort
Journal of Translational Medicine 2019, vol. 17, issue 1
doi: 10.1186/s12967-019-2100-3